A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

So far this year, influenza cases are nearly 20 per cent higher than they were last year, and 2,800 cases were recorded in ...

Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...

Pneumagen has announced the publication of phase 2 data showing its antiviral therapy, Neumifil, significantly reduced ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...